Head of Investor Relations; Sr. Director​/VP, title DOE - publicly traded

The Head of Investor Relations (Senior Director, VP, DOE) will lead the company’s investor relations program for a publicly traded, global med tech organization. Reporting directly to the Head of Corporate Finance, this role is responsible for shaping and executing a clear, credible, and consistent investor narrative that reflects the company’s strategy, financial performance, and long term value creation.

This role requires a strong foundation in investment banking, ideally with med tech or healthcare sector coverage, and the ability to operate with confidence in a highly visible, regulated, and performance driven public company environment.

• Develop and execute a comprehensive investor relations strategy aligned with the company’s business strategy, financial objectives, and capital markets priorities.
• Own the company’s external investment narrative, ensuring consistency across earnings materials, investor presentations, public disclosures, and executive messaging.
• Partner closely with the CFO and CEO to prepare earnings call scripts, Q&A, analyst day materials, and investor presentations.

• Lead preparation of quarterly and annual earnings materials, including press releases, slide decks, scripts, FAQs, and investor website content.
• Ensure accuracy, consistency, and compliance with SEC regulations, Reg FD, and other public company disclosure requirements.
• Collaborate with Finance, Legal, and External Communications to support 10‑K, 10‑Q, proxy, and other required disclosures from an investor relations perspective.
• Serve as a primary point of contact for institutional investors, sell‑side analysts, and rating agencies.
• Coordinate and participate in earnings calls, investor conferences, non‑deal roadshows, and one‑on‑one investor meetings.
• Build and maintain strong, long‑term relationships with the investment community, ensuring transparency and credibility.
• Monitor investor sentiment, analyst coverage, peer performance, valuation trends, and broader med‑tech capital markets dynamics.
• Synthesize market feedback and provide actionable insights to the CFO and executive leadership team.
• Support strategic initiatives including capital allocation decisions, M&A communications, and long‑term financial targets.
• Prepare investor‑related materials for Board of Directors meetings, including market updates, shareholder feedback, and valuation analysis.
• Act as a trusted advisor to senior leadership including the CEO and CFO on investor expectations, messaging risks, and market perception.

• Bachelor’s degree in Finance, Economics, Business, or a related discipline.
• 4-10+ years of experience in investment banking, equity research, and/or investor relations, with meaningful exposure to public company dynamics.
• Strong financial modeling, valuation, and analytical skills.
• Demonstrated experience interacting with institutional investors and sell‑side analysts.
• Exceptional written and verbal communication skills, with executive presence.

• Investment banking experience covering med‑tech, medical devices, or healthcare companies
  .
• Prior in‑house investor relations experience at a publicly traded company.
• MBA, CFA, or similar advanced credential.
• Experience supporting capital markets transactions (IPO, follow‑on offerings, debt issuance) and M&A communications.
• Deep understanding of public company financials and capital markets.
• Strategic, investor‑centric mindset.
• High integrity and strong judgment in disclosure matters.
• Ability to manage high‑visibility work under tight deadlines.
• Collaborative partner with Finance, Legal, Communications, and Executive Leadership.